
Pictured (l to r) at the ceremony are Jennifer Pearl, President, Bloomington Economic Development Corporation; Denis Johnson, General Manager, Catalent Bloomington; Barry Littlejohns, President, Biologics and Specialty Drug Delivery, Catalent; John Chiminski, Chair & CEO of Catalent; Eric Holcomb, Governor of Indiana; Mick Renneisen, Deputy Mayor, Bloomington; Mike Riley, VP/GM Catalent Biologics; and Kay Schmidt, SVP Technical Operations, Catalent
Catalent recently held a ground-breaking ceremony at its Bloomington (Indiana, US) site to mark the start of construction on a US$112m drug product manufacturing facility, which will increase fill/finish capacity in Bloomington by 79,000 square feet.
The facility will house a high-speed vial line utilising both ready-to-use components and bulk filling, a high-speed flexible syringe/cartridge line, a fully automated vial inspection machine and all associated services and support areas.